availability of semaglutide When it comes to versus tirzepatide for weight loss, the “best” choice is never one-size-fits-all. At a premium, medically guided level, we compare how each option supports appetite regulation, metabolic response Novo cuts GLP-1 prices 70%,

Licensed 503A compounding ensures pharmaceutical-grade quality: each vial meets United States Pharmacopeia (USP) standards for sterility, strength, and purity

Both Eli Lilly and Novo Nordisk have spoken out against the use of off-brand versions of tirzepatide and semaglutide, respectively

[DOI] [PMC free article] [PubMed] [Google Scholar] [81].Cone JJ, Roitman JD, Roitman MF Ghrelin regulates phasic dopamine and nucleus accumbens signaling evoked by food-predictive stimuli

The study showed a 13% reduction in major adverse cardiovascular events (MACE), a composite endpoint for cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, in patients treated with liraglutide compared with placebo at a mean follow-up of 3.8 years (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.780.97) and a significant reduction in cardiovascular death (HR 0.78, 95% CI 0.660.93)

Rebil Heiru Jemal, Department of Internal Medicine, Adama Hospital Medical College, Adama 1000, Ethiopia

Recognizing NAION Vision Symptoms in GLP-1 Users Early warning signs of NAION in GLP-1 users may include: Sudden, painless vision loss, often noticed upon waking Blurring or darkening in part of the visual field Difficulty perceiving colors, especially reds Loss of contrast sensitivity Its crucial to differentiate NAION from other vision problems